发明名称 |
Material and method for treating internal cavities |
摘要 |
A hydrophilic biocompatible sustained-release material is disclosed. The material comprises amounts of Pluronic F-127, PEG-400, HPMC and water, effective to produce a composition of sufficiently low viscosity at room temperature to be injectable into an internal body cavity via a tube inserted within a urinary catheter. At body temperature, the material exhibits a much higher viscosity and will stably adhere to the internal surface of a body cavity. As the material dissolves, a therapeutic agent incorporated therein is slowly released to the body cavity, while the material itself is excreted from the body. |
申请公布号 |
US9040074(B2) |
申请公布日期 |
2015.05.26 |
申请号 |
US201213553198 |
申请日期 |
2012.07.19 |
申请人 |
Theracoat Ltd. |
发明人 |
Holzer Asher;Daniel Dorit;Mullerad Michael;De La Zerda Jaime;Shpolansky Uri;Malchi Nadav;Dollberg Yosh;Tal Dor;Yavin Yossi;Konorty Marina |
分类号 |
A61K47/34;A61K9/00;A61K9/06;A61K47/10;A61K47/38 |
主分类号 |
A61K47/34 |
代理机构 |
JMB Davis Ben-David |
代理人 |
JMB Davis Ben-David |
主权项 |
1. A thermoreversible hydrogel, comprising:
between 20% and 30% (w/w) of an ethylene oxide/propylene oxide triblock copolymer characterized by an average molar mass of 13000 and a general formula E106 P70 E106; between 0.05% and 0.3% HPMC; between 0.4and 2.5% PEG-400; an effective amount of a therapeutic agent; and the balance water. |
地址 |
Ra'anana IL |